Record profits and margin expansion: Can HDB sustain the momentum into Q2?
After an exceptional Q1 FY27—profit at an all-time high—HDB Financial enters Q2 having just raised ₹20,000+ Cr in NCDs. The Street debates whether margin widening holds and credit costs stay benign. Technically oversold at ₹600, but fundamentals remain intact.
HDB Financial Services steps into Q2 FY27 on an extraordinary high. Q1 delivered the company's best-ever quarterly profit—₹785.2 Cr, up 38.3% YoY—on the back of widening credit margins and benign credit costs. But the real story was the *gap*: revenue grew a modest 10.6% YoY to ₹4,937.9 Cr, while profit more than doubled the growth rate. That gap is the entire question for Q2. If margins compress, or if credit costs normalise, the profit growth story stalls. If they hold, HDB has shifted to a new earning curve.
What to expect in Q2
~₹4,900–5,150 Cr
on-plan with 10–12% YoY growth trajectory from Q1; AUM growth momentum to watch
~₹620–680 Cr
moderating from Q1's record ₹785 Cr, but still 13–20% YoY growth (vs Q2 FY26's ₹581 Cr)
Expect resilience
if Q1's widening (from better mix, lower cost of funds) sustains; credit cost trajectory is the swing
Management-silent
HDB does not provide explicit earnings or AUM guidance; Street watches for cues on FY27 full-year trajectory
A strong Q2 would show: (1) revenue growth sustained at 10%+, evidence of AUM expansion in the 14%+ YoY range (per Q1 customer growth of 2.2 Cr, up 14.6% YTD); (2) credit costs well-controlled (i.e., continued margin support); (3) interim dividend announced by the board, signalling confidence in capital adequacy post-raise. A weak Q2 would flag: (1) revenue growth slipping below 8% (suggesting macro pressure on lending); (2) NIM compression from normalising credit costs; (3) forward guidance caveats or a passed dividend.
On track with guidance?
HDB does not provide explicit full-year earnings guidance. The company's long-term trajectory—AUM growth in the 12–15% range, mid-to-high teen ROE, and aspirational 18%+ post-tax margin—is management commentary, not a formal guide. Q1 FY27 *exceeded* that with PAT margin of ~15.9%. For Q2, the key is whether that margin is sustainable or a Q1 anomaly. If benign credit costs were a one-quarter feature, profit growth will normalize. If it's structural (better customer mix, deposit pricing discipline), the stock's 25% pullback from ATH may be overblown. The board's dividend decision will be read as a confidence signal.
What the Street expects
Since last quarter
Jul 15
PAT ₹785.2 Cr (+38.3% YoY); revenue ₹4,937.9 Cr (+10.6% YoY); interim dividend announced
Q1 FY27 results
Jul 28
Jimmy Tata appointed as Non-Executive Director (HDFC Bank nominee); later ceased Aug 14 post term-completion
Board appointment
Jul 02–Sep 09
₹1,000 Cr + ₹310 Cr + ₹400 Cr + ₹300 Cr + ₹544.5 Cr + ₹20,181 Cr secured NCDs allotted; total raise ₹22,735+ Cr in Q2
Heavy NCD issuances
Jul 15
Submitted quarterly monitoring report confirming proper utilization of FY26 IPO proceeds; regulatory compliance routine
IPO proceeds monitoring
Oct 07–14
Convenes Oct 14 to consider & approve unaudited Q2 FY27 results and interim dividend
Board meeting (intimated)
Operational read: No surprises. The heavy NCD raise (₹22,735 Cr in ~3 months) is aggressive but routine for a NBFC in growth mode—HDB is financing a 14%+ customer base expansion. The director churn (Jimmy Tata) was a one-off directorship completion, not a governance flag. The interim dividend (Jul, expected again Oct) signals management confidence. Ownership remains stable: promoter (HDFC Bank) 74.12%, FII +55 bps QoQ to 3.55%, DII 12.10%.
The setup
HDB Financial enters earnings season as a tale of two narratives. Bull case: Q1's record profit, margin expansion, and 38% earnings growth reflect a company hitting operational stride—better loan-pricing power, lower wholesale cost of funds, and tight credit losses. The NCD raise is fuel for 14%+ AUM growth; the interim dividend is a confidence signal. At ₹600, the stock is oversold (RSI 19.6, below all SMAs), and ₹775 target implies 29% upside. Bear case: Margin widening may be a one-quarter feature from benign credit costs; normalising rates and credit normalization could compress the gap. The stock is down 25% from ATH for a reason—macro caution, and execution risk on the lending-growth ramp. Q2 will test which story holds.
1 · NIM and credit-cost trajectory
Does Q1's margin expansion persist or compress? Management commentary on provisioning and slippages (especially in auto/commercial vehicles, where HDB has exposure) will tell the story. Watch the cost-of-funds trajectory—lower wholesale rates are a tailwind, but deposit competition is rising.
2 · AUM growth and customer momentum
Q1 delivered 14.6% YTD customer growth (2.2 Cr base). Is that rate sustaining into Q2, or has macro caution (RBI rate pause, slower vehicle offtake) slowed origination? AUM growth is the lead indicator for next quarter's revenue.
3 · Dividend & forward tone
The Oct 14 board meeting is expected to announce the interim dividend (precedent: ₹3/share in Jul). Management's tone on capital adequacy (post ₹22k Cr raise) and any FY27 full-year cues will either validate the ₹775 target or invite caution from the Street.
HDB Financial's Q2 FY27 is a litmus test for the durability of margin expansion. Q1 was a home run—record profit, 38% earnings growth, and the widening margin gap suggested a company in command of its earning curve. But single-quarter outliers can fool. If Q2 sustains NIM, profit growth stays in the high teens or better, and the board signals confidence (dividend, tone), the stock's 25% pullback from ATH is a gift for tactical buyers near the ₹775 target. If margins compress and credit costs normalise, the stock may test ₹600 support or lower, and the Street will re-rate HDBFS as a mid-teen growth, single-digit margin story—not the high-flying wealth-manager play of Q1. Earnings on Oct 14 will settle the debate.
Strong growth, margin hold — festive season key for H2
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade A
Hit NIM guidance (8.23% vs 8%+ target). ROA 2.42% vs 2.5% target, marginal miss. Credit cost 237bps in stated range.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Solid growth momentum (18% disbursements, 34% PAT) and improving cost efficiency, but sequential NIM compression to 8.23% from 8.35% and PAT decline QoQ suggest margin pressures offsetting volume gains. H2 festive season critical to re-accelerate on near-term basis. Management confident but not aggressive; guidance maintained, not upgraded.
₹5005.3 Cr
Revenue · +10.1% YoY₹780.2 Cr
Reported PAT · +34.2% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
PAT grew 34% YoY to ₹780 Cr
MET₹780.2 Cr, YoY +34.2%, verified
Disbursements +18% YoY, ₹18,522 Cr
METManagement stated 18.7% YoY, ₹18,522 Cr exact
NIM at 8.23%, expected to hold at 8%+
METQ2 delivered 8.23%, vs 7.95% Q2FY26, vs 8.35% Q1FY27 (QoQ compression)
ROA targeting 2.5%
OVERSTATEDDelivered 2.42% annualized Q2, below target but close
Asset Finance turning corner from Q3
PartialCV +8% YoY, CE +12% YoY Q2, modest. Acknowledged delinquent book stretch.
Earnings quality
What changed since the last call
NIM guidance maintained, execution tracking
NeutralQ2 NIM 8.23% holds target of 8%+. Prior Q1 was 8.35%, so QoQ compression noted but not a guidance miss.
Asset Finance trajectory from 'weak' to 'turning corner'
UpgradeQ1 call flagged Asset Finance challenges. Q2 shows CV +8%, CE +12% YoY growth. Delinquent book still being worked, but management now confident Q3 will show normalization.
Cost efficiency improving
UpgradeCost-to-income 39.3% Q2 vs 40.7% Q2FY26. Better than Q1FY27 (39.9%), showing productivity from AI initiatives gaining traction.
Customer franchise growth acceleration
UpgradeCustomer franchise 24.8M (+18.4% YoY vs 22.9M prior year). Growth momentum in onboarding outpacing loan growth.
The Q&A
Analysts pressed hard on NIM sustainability (Renish), Asset Finance used vehicle slowdown (Abhijit), asset quality Stage 2 buildup (Raghav), and growth deceleration (Avinash, Viral). Management held firm on margin management strategy and provided detailed product-level context. No dodging, but some hedging on specific forward growth rates.
NIM outlook & asset yield — Renish, ICICI Securities
AnsweredFrom NIM standpoint, we're at 8.23%, pretty much in line. We expect to hold at 8%+. Rates started peaking in Q2; we've had Q1 product mix impact but expect to pull back.
Fixed-rate borrowing composition — Renish, ICICI Securities
AnsweredNCDs at 8.25-8.2%, LAP on floating. Cost of borrowing 7.04%. Will manage calibrated repricing; not expecting major NIM impact.
Asset Finance growth weakness — Abhijit Tibrewal, Motilal Oswal
AnsweredNew hitting budgets. Used has internal actions underway; we expect turnaround as we go through Q3 and Q4. Combination of new growth and used improvements.
Drought and OPEX — Shreya Shivani, Nomura
AnsweredDrought exposure small, no crop loans at NBFC level. OPEX improved from 40.7% to 39.3% YoY. Focus on AI-driven onboarding reducing sales person time; delivering more customers per head.
Asset quality Stage 2/3 buildup — Raghav Garg, Ambit Capital
AnsweredCV and CE seasonality. Expect reversion in coming quarter. Not completely stressed, just seasonal effect from Q1 product mix impact.
Growth pace and FY28 outlook — Viral Shah, IIFL Capital
PartialHopeful Q4 shows uptick. On cost of funds, we're working hard to manage borrowing in manner that increase is as low as possible. Treasury function balancing instrument mix.
Credit cost guidance — Shreepal Doshi, Equirus
AnsweredSeasonality on book growth. Target credit cost 2.3% for full year, ±5bps. Expected to flow back in coming quarter.
AUM growth and used vehicle quality — Vinod Rajamani, Nirmal Bang
AnsweredEach business is complete focus area. LAP growing 3-3.5% QoQ. Unsecured loans at 0.2% positive now turning. Challenges in longer-dated delinquent book but expect turnaround Q3-Q4.
LAP business model and repricing — Rajiv Mehta, YES Securities
AnsweredFloating rate book with floating reference rate updated 16th of every month. LAP book primarily ₹24.6M average ticket. 800+ cities distribution. Prepayment part of business model; we price accordingly.
Repricing strategy on assets — Nischint, Kotak
AnsweredLAP will show increase in near term. Other products calibrated increase. NCD rates now 8.2%+, have ability to reprice. Focus on not losing NIM over next 12 months and manage ALM carefully.
Growth and profitability outlook — Avinash Singh, Emkay Global
PartialGrowth relative term; others 25%, slowdown 20%. Focus on 2.5% RoA annually. Investments in AI, not letting cost balloon. Growth and RoA balance the key focus for next 12-18 months.
Fee income outlook — Prithviraj Patil, Investec
PartialLast year ₹455 Cr fee income, ~0.3% on RoA. Rules crystallizing; when they do, we'll come and talk on strategy for insurance side.
Guidance
No formal revenue target; management expects 12-18% growth in disbursements
MediumQ2 delivered 18.7% disburse growth. H2 expected strong on festive season. Full year growth calibrated by sector headwinds (Asset Finance recovery phased).
NIM to remain at 8%+ in near to medium term
MediumQ2 delivered 8.23%. Rate cycle tightening is headwind; management focused on managing repricing and borrowing cost calibration.
No specific capex target; AI and tech investments ongoing but absorbed in opex efficiency gains
LowCost-to-income improving suggests capex return on employee productivity. No separate guidance provided.
Risks the call surfaced
Margin compression
MediumCost of borrowing rising (NCDs 8.2%+, repo 7.04%). Asset repricing lagging liability repricing. Sequential NIM compression 8.35% to 8.23%.
Asset Finance quality
MediumCV and CE portfolios showing Stage 2 buildup in Q2. Longer-dated delinquent book acknowledged as ongoing challenge. Assumption of turnaround in Q3 may slip.
Execution on ROA target
LowQ2 ROA 2.42% annualized, below stated 2.5% target. Achieving target requires both growth and margin hold simultaneously.
Sector cyclicality & macro sensitivity
MediumH2 festive season is key catalyst for momentum. Economic slowdown or consumer spending contraction could derail growth assumptions.
Regulatory & insurance commission
LowInsurance commission rules under regulatory review. Management deferred specifics to 'when rules crystallize'. Current fee income ₹455 Cr could face pressure.
Management
Score 7/10. Clear, detailed, and substantive. Management provided specific numbers, product-level context, and acknowledged challenges candidly (Asset Finance turnaround pending, margin pressure from rates). Track record solid. Hit NIM guidance (8.23% vs 8%+). ROA 2.42% vs 2.5% target (close). Credit cost in range. Revenue growth 10.1% YoY solid but not exceptional; PAT 34% YoY strong.
1 · Q3 FY27
Festive season demand expected to drive Consumer Finance and Enterprise Lending
2 · Q3 FY27
Asset Finance recovery expected (CV/CE delinquent book normalization)
3 · H2 FY27
AI-driven customer onboarding and collections to improve productivity metrics
Management confident but not aggressive; guidance maintained, not upgraded.
HDB Financial Q2 FY27: PAT up 34% YoY to ₹780 Cr, NPM expands to 15.6%, beats Street
PAT +34.19% YoY · revenue +10.12% · margins expanding · beat vs street
₹5,005.3 Cr
+10.12% YoY
₹780.2 Cr
+34.19% YoY
15.59%
+2.8pp YoY
₹9.39
HDB Financial Services' standalone PAT for Q2 FY27 came in at ₹780.2 Cr, up 34.2% YoY from ₹581.4 Cr, and roughly flat QoQ (-0.6%) against the record ₹785.2 Cr printed in Q1 FY27. Revenue from operations rose 10.1% YoY and 1.4% QoQ to ₹5,005.3 Cr. The print beat the ₹620-680 Cr PAT range the Street had pencilled in pre-result, while revenue landed within the ₹4,900-5,150 Cr expected band — profitability, not topline, was the surprise this quarter.
Q2 FY-2027 vs prior quarters
The beat was driven by operating leverage rather than a tax one-off: pre-tax profit rose 33.4% YoY to ₹1,043.7 Cr, and tax expense grew a similar 31.2% to ₹263.5 Cr, keeping the effective tax rate near 25.3%, in line with a year ago. Total expenses grew only 5.3% YoY to ₹3,961.6 Cr against 10.1% revenue growth — impairment/credit costs actually fell 2.5% YoY to ₹729.9 Cr even as the net loan book expanded to ₹1,20,379 Cr, while finance costs grew a slower 7.3% YoY than revenue. Net profit margin expanded to 15.59% from 12.79% a year ago, though it slipped 31bps sequentially from 15.90% in Q1, as impairment and finance costs both outpaced revenue quarter-on-quarter.
The stock went into the print at ₹584.55, down 12.6% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
EPS (basic) ₹9.39 for the quarter vs ₹7.01 a year ago and ₹9.46 last quarter
Management expressed confidence in continued positive momentum across most business segments, particularly Consumer Finance and Enterprise Lending, with a strong focus on AI-driven transformation for long-term customer engagement. While Asset Finance is undergoing a strategic rejig for better risk-adjusted returns, gro
— This quarter: met
Management's July guidance targeted NIM above 8%, a 2.5% ROA and steady-state credit costs near 2.3%. On the reported numbers, annualised ROA (quarterly PAT annualised over average total assets) works out to roughly 2.45% — essentially on target — while annualised credit cost of ~2.5% of average loans sits a touch above the 2.3% steady-state goal, though improving asset quality (Gross Stage 3 down to 2.43% from 2.81% YoY; Net Stage 3 down to 1.09% from 1.27%) supports the trend. At the segment level, Lending business PBT rose 35.6% YoY to ₹1,041.8 Cr and drove the quarter, while BPO services profit fell 37.8% YoY to ₹17.9 Cr; the filing does not break Asset Finance out from the combined Lending segment, so the promised sub-segment "pickup from Q2 onwards" can't be verified from these numbers alone. The company raised NCD funding through the quarter (including a ₹20,181 Cr allotment announced September 9, 2026), and the Board declared an interim dividend of ₹2.00/share (record date October 23, 2026) alongside results. No management press release accompanied this filing, so there is no fresh quarter-specific commentary beyond the July concall guidance to reconcile against.
W1
Credit-cost run-rate (~2.5% of average loans this quarter, annualised) against management's 2.3% steady-state target
W2
BPO services segment profit fell to ₹17.9 Cr (-37.8% YoY) from ₹28.8 Cr — watch for recovery
W3
Asset Finance segment-specific growth 'pickup from Q2 onwards' isn't separately disclosed (combined into Lending segment) — confirm via next quarter's commentary
Company has no subsidiaries/associates (filing note 15), so only standalone results exist; figures converted from Rs. in million (÷10) to Rs. Crore; no separate other-income line in this NBFC format, so totalIncome = revenueFromOperations.
Growth at the Cost of Margins — A Profit That Won't Sustain
HDB Financial posted 34% YoY profit growth, but sequential profit fell 0.6% despite 1.4% revenue growth. The margin compression from rising rates is real, and the market's 7.65% sell-off on day 1 says it sees a quarter of volume without profitability.
₹780.2 Cr
YoY +34.2% | QoQ -0.6%
15.6%
vs 15.7% Q1 (compression)
8.23%
held guidance, but -12bps QoQ
₹18,522 Cr
+18.7% YoY (strong)
The headline reads like a win: PAT jumped 34% year-over-year. But flip to the sequential numbers and the story inverts. Profit was flat quarter-on-quarter despite revenue rising 1.4%. That's the red flag the market saw — and on day 1, the stock fell 7.65% with 86.8% delivery, showing conviction in the sell. The quarter is a case study in growth without profitability: volume is up, but unit margins are crumbling under the weight of a tightening rate cycle.
Where the margin went
Revenue grew just 10.1% year-over-year, a disconnect from the 18.7% growth in disbursements. That gap is product mix: while disbursement volumes are climbing, the yield on those loans is being pressured by the rate cycle and competitive intensity. Net interest margin compressed 12 basis points quarter-on-quarter (8.35% in Q1 to 8.23% in Q2). The cost of funds is the culprit: NCDs are now yielding 8.2%+, and the cost of borrowing sits at 7.04%. Management is repricing assets, but the lag between liability cost (moving up fast) and asset repricing (slower) is squeezing the spread.
NIM to remain at 8%+. We expect to hold at 8%. Rates started peaking in Q2; we've had Q1 product mix impact but expect to pull back.
That statement — expect to pull back — is the moment management pivoted from confidence to hope. The company hit its 8%+ NIM guidance, but only at the cost of sequential compression. If rates stay elevated in H2, even that 8% floor is at risk.
What management's claims say vs. what the numbers show
"PAT grew 34% YoY to ₹780 Cr"
₹780.2 Cr, YoY +34.2% — accurate. But QoQ -0.6%, a material miss.
Supported (but incomplete)
"Disbursements +18.7% YoY, ₹18,522 Cr"
Exact match to reported.
Supported
"NIM will hold at 8%+"
Q2 delivered 8.23%, meeting the 8%+ target. But Q1 was 8.35% — QoQ decline breaks the hold narrative.
Technically supported, strategically overstated
"Asset Finance turning corner from Q3"
CV +8% YoY, CE +12% YoY in Q2. Management acknowledged a 'longer-dated delinquent book' still being worked. Recovery is a Q3 assumption, not a Q2 reality.
Partial (recovery timing uncertain)
"ROA targeting 2.5%"
Q2 delivered 2.42% annualized, a 8-basis-point miss. Not close enough.
Slightly overstated
What changed on this call
Cost-to-income improved to 39.3% from 40.7% YoY — efficiency gains from AI onboarding and collections automation are real
Customer franchise accelerated to 24.8M (+18.4% YoY) — onboarding outpacing loan growth, a positive signal
Asset Finance narrative shifted from "weak" to "turning corner" — but execution still unproven (recovery in Q3 is a bet, not a done deal)
Guidance maintained, not raised — a yellow flag in a quarter where disbursement growth was strong
The bull-bear ledger
Disbursement growth 18.7% YoY, all segments contributing, strong pipeline for H2
Cost efficiency improving (C/I 39.3%); AI productivity initiatives delivering early gains
Customer franchise +18.4% YoY to 24.8M; relationship growth >loan growth
Capital adequacy 21.37%, ample headroom for growth and rate cycle
Sequential NIM compression 12bps; margin hold is fragile under rate pressure
Sequential PAT flat despite revenue growth; unit profitability eroding
Asset Finance delinquent book acknowledged; turnaround timeline uncertain
H2 growth dependent on festive season — one miss = full-year miss
Ranked risks — what should concern a holder
NIM compression from rate cycle tightening
HighCost of funds rising (NCDs 8.2%+, repo 7.04%). Asset repricing lagging. QoQ NIM fell 12bps; if trend continues, 8% guidance breaks. Management has limited pricing power.
Sequential profit flat while revenue grows
HighUnit economics are deteriorating. A 1.4% revenue gain should push profit higher, not flat. If this ratio repeats, profitability growth will decouple from volume growth.
Asset Finance delinquent book and recovery timing
MediumLonger-dated CV/CE delinquent portfolio acknowledged. Q3 normalization is an assumption. If delayed, Stage 3 will rise, credit costs exceed 2.3% guidance, and earnings will miss.
Festive season H2 is a single point of failure
MediumManagement repeatedly cited H2 festive demand as key to momentum. Consumer Finance growth is 25% YoY, tied to discretionary spend. Economic slowdown or weak festival demand would torpedo guidance.
ROA target of 2.5% vs. delivered 2.42% (and widening gap if margins compress further)
MediumAchieving 2.5% requires growth AND margin hold. Sequential compression suggests gap will widen. Management may need to recalibrate expectations.
How the street is positioned — price action & flows
The market voted on day 1: -7.65% sell-off with 86.8% delivery, announced Oct 14, 2026. That conviction in the sell is telling. The stock closed pre-result at ₹583.75; it now trades at ₹509.05, down 42.93% from its all-time high of ₹891.9. The oversold condition (RSI 20.4) suggests capitulation, but this is not yet a recovery signal — it's a repricing to reality.
The stock trades below its 20-day (₹609.77), 50-day (₹653.77), and 200-day (₹681.98) moving averages. The 52-week range is ₹504.1–₹796.7; at ₹509, the stock is near the lows, having lost nearly half its value from the highs. Volume is increasing, suggesting the move is not passive capitulation but active exit by institutional money.
On ownership, FII holding is flat at 3.55% (up 54bps QoQ), while DII dipped 18bps to 12.10%. Promoter steady at 74.12%. The FII flatness is notable — in a selloff, flat FII often means foreign institutions are not buying the dip. The market's message: profitability under pressure, not yet a bargain.
The day-1 sell-off is fundamentally justified. The quarter shows growth that is not flowing to the bottom line — exactly the earnings quality concern that triggers institutional exits. The oversold technicals may offer a bounce, but not a reversal, until margin pressure shows signs of stabilizing.
The debate
The honest read: This is not a broken quarter — it is a warning quarter. The company is growing top-line aggressively (18.7% disbursements), but the rate cycle is eroding the margin structure. Management is holding guidance (NIM 8%+, ROA 2.5%) but executing below targets (NIM flat sequentially, ROA 2.42%). The gap between the narrative ("confident," "festive season will be strong") and the delivery (sequential profit decline, margin compression) is widening. The market is right to be skeptical.
This is a steady-execution story with execution gaps, not a step-change. The stock is repricing from growth-at-any-cost to growth-with-margins-intact, and it hasn't found bottom yet.
What to watch next
1 · Q3 NIM trend: does it stabilize at 8.2%+ or break below 8%?
If NIM holds 8.23% or improves, the compression is Q2-specific. If it dips below 8%, the rate cycle is winning and guidance breaks. This is the single number to track.
2 · Asset Finance Stage 3 and delinquent book: does Q3 show normalization or buildup?
Management assumes Q3 turnaround. If Stage 3 rises or delinquent book stretches, credit costs exceed 2.3% guidance and earnings miss. This resolves the execution risk.
3 · Sequential PAT growth in Q3 and H2: does festive season unlock profitability leverage?
For the bull case to hold, H2 needs to show PAT growing faster than revenue for 2–3 consecutive quarters. If sequential profitability remains flat or negative, the margin compression is structural, not cyclical, and fair value resets lower.
HDB Financial is a company in transition: from rate-cycle tailwind (2021–2023) to rate-cycle headwind (2024+). The quarter shows what that headwind looks like — strong volume growth (18.7% disbursements) that does not translate to strong profit growth (PAT +0.6% YoY on reported basis, -0.6% QoQ). The company is executing on cost (C/I improving, customer franchise accelerating), but not on margins (NIM compressing, ROA missing). Management's guidance is holding, but not raising — a sign of measured caution.
At ₹509, the stock is oversold but not yet a bargain. The market's 7.65% sell-off on day 1 was the right call — the quarter exposed the tension between growth and profitability that the FY27 narrative had papered over. The debate for the next 6–9 months is whether management can stabilize margins while maintaining growth momentum. Until Q3 NIM data arrives, the stock will remain in repricing mode, vulnerable to further downside if Asset Finance misses or festive season demand disappoints.
The number to track from here is the quarter-on-quarter NIM trend. If it stabilizes at 8.2%+ in Q3, the margin pressure is temporary and the 500s are a buy. If it breaks below 8%, the structural headwind is real and the stock has more downside. Neither is priced in yet — but the market is waiting for the proof.